Lansoprazole vs Pembrolizumab

## Lansoprazole vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Lansoprazole** and **Pembrolizumab**.

## Mechanism of Action

**Lansoprazole**: Proton pump inhibitor.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Lansoprazole — 1.5 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Lansoprazole — C16H14F3N3O2S; Pembrolizumab — N/A.

**Molecular Weight**: Lansoprazole — 369.3620 g/mol; Pembrolizumab — N/A.

**Type**: Lansoprazole — Small molecule; Pembrolizumab — Antibody.